CFTR and Azoospermia: Additional targeted molecular tests were applied based on clinical indication: Y chromosome microdeletion analysis in azoospermia or oligospermia, <i>CFTR</i> sequencing in suspected congenital bilateral absence of the vas deferens, and <i>F2</i>/<i>F5</i> genotyping in recurrent pregnancy loss (RPL).